Metro Inc
MRU: XTSE (CAN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| $> | LOCK|xb | LOCK|$lSzlnq |
Metro Earnings: Pharmacy Results Resilient but Investments are Needed to Support Grocery Positioning
Metro's sales grew 3.4% in the fourth quarter of fiscal 2025, driven by same-store sales growth of 1.6% and 4.8%, respectively, in food retail and pharmacy, while floor space grew 1.4%. Adjusted EPS rose 10.8% on margin lift from distribution efficiency gains and a 3% reduction in share count.
